Table 2 Outcome of in vitro expansion of γδ T cells from PBMC of AML patients
P | % γδ T cells IL-2+zoledronate | % γδ T cells IL-2+IL-15+zoledronate | Success |
|---|---|---|---|
A | 75.9 | 91.9 | Yes |
B | 16.8 | 12.4 | No |
C | 84.4 | 94.0 | Yes |
D | 17.2 | 46.6 | No |
Dr | 76.6 | 89.4 | Yes |
E | 5.65 | 1.80 | No |
F | 4.31 | 1.84 | No |
Gr | 27.1 | 50.8 | No |